UMediC Group Bhd
KLSE:UMC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBITDA returns to its 3-Year Average (14.1), the stock would be worth MYR0.62 (113% upside from current price).
| Scenario | EV/EBITDA Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 6.6 | MYR0.29 |
0%
|
| 3-Year Average | 14.1 | MYR0.62 |
+113%
|
| 5-Year Average | 14.4 | MYR0.63 |
+117%
|
| Industry Average | 12.4 | MYR0.54 |
+87%
|
| Country Average | 11.3 | MYR0.5 |
+71%
|
Forward EV/EBITDA
Today’s price vs future ebitda
| Today's Enterprise Value | EBITDA | Forward EV/EBITDA | ||
|---|---|---|---|---|
|
MYR102.5m
|
/ |
Feb 2026
14.4m
|
= |
|
|
MYR102.5m
|
/ |
Jul 2026
12.9m
|
= |
|
|
MYR102.5m
|
/ |
Jul 2027
13.9m
|
= |
|
|
MYR102.5m
|
/ |
Jul 2028
14.8m
|
= |
|
Forward EV/EBITDA shows whether today’s EV/EBITDA still looks high or low once future ebitda are taken into account.
Peer Comparison
| Market Cap | EV/EBITDA | P/E | ||||
|---|---|---|---|---|---|---|
| MY |
U
|
UMediC Group Bhd
KLSE:UMC
|
108.4m MYR | 6.6 | 13.3 | |
| US |
|
Mckesson Corp
NYSE:MCK
|
102.8B USD | 16.7 | 23.7 | |
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
62.9B USD | 13.7 | 38.7 | |
| US |
|
Cencora Inc
NYSE:COR
|
60.6B USD | 13.2 | 37.3 | |
| US |
|
Cardinal Health Inc
NYSE:CAH
|
48.3B USD | 14.1 | 29.1 | |
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
32.4B AUD | 26.1 | 35.2 | |
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
62.9B CNY | 8.6 | 11 | |
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
9.1B USD | 11.1 | 22.8 | |
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
59.9B CNY | 12.5 | 16.2 | |
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 59.9 | 89.6 | |
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
61.9B HKD | 0.6 | 7.7 |
Market Distribution
| Min | 0.5 |
| 30th Percentile | 7.2 |
| Median | 11.3 |
| 70th Percentile | 16.9 |
| Max | 56 436.5 |
Other Multiples
UMediC Group Bhd
Glance View
UMedic Group Bhd.is an investment holding company, which engages in the marketing and distribution of medical devices and consumables through its subsidiaries. The company is headquartered in Penang, Pulau Pinang. The company went IPO on 2022-07-26. The Company, through its subsidiaries, is principally involved in marketing, distribution and manufacturing of medical devices as well as the provision of aftersales service. The company is also developing, manufacturing and marketing of medical consumables, namely HydroX series prefilled humidifiers. Its products include Patient monitor / MRI-compatible patient monitor, Defibrillator/AED, General anaesthesia machine, Ventilator, Maternal and infant care, Ultrasound machine, Electric-powered three dimensional (3D) chest compressor, and Furniture’s such as medical bed, medical cart, Pressure transducer kit, Arterial cannulation, Arterial blood sampling systems, and Central venous catheter. The firm markets and distributes its products to more than 400 customers comprising public and private hospitals, other healthcare service providers such as medical centers and other healthcare-related facilities, as well as non-hospitals.
